Article
Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
Human gene therapy methods - 1 Apr 2013
Okamoto Mika, Chono Hideto, Kawano Yasuhiro, Saito Naoki, Tsuda Hiroshi, Inoue Koichi, Kato Ikunoshin, Mineno Junichi, Baba Masanori
Abstract excerpt
Gene therapy using a Tat-dependent expression system of MazF, an ACA nucleotide sequence-specific endoribonuclease derived from Escherichia coli, in a retroviral vector appears to be an alternative approach to the treatment of human immunodeficiency virus type 1 (HIV-1) infection. MazF can cleave HIV-1 RNA, since it has more than 240 ACA sequences. Significant inhibition of viral replication, irrespective of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
